<VariationArchive VariationID="2003636" VariationName="NM_015506.3(MMACHC):c.648dup (p.Glu217fs)" VariationType="Duplication" Accession="VCV002003636" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2051693" VariationID="2003636">
      <GeneList>
        <Gene Symbol="LOC129930446" FullName="ATAC-STARR-seq lymphoblastoid active region 972" GeneID="129930446" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45508965" stop="45509054" display_start="45508965" display_stop="45509054" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MMACHC" FullName="metabolism of cobalamin associated C" GeneID="25974" HGNC_ID="HGNC:24525" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45500300" stop="45513382" display_start="45500300" display_stop="45513382" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45965855" stop="45976738" display_start="45965855" display_stop="45976738" Strand="+" />
          </Location>
          <OMIM>609831</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015506.3(MMACHC):c.648dup (p.Glu217fs)</Name>
      <CanonicalSPDI>NC_000001.11:45509013:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45509013" stop="45509014" display_start="45509013" display_stop="45509014" variantLength="1" positionVCF="45509013" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45974685" stop="45974686" display_start="45974685" display_stop="45974686" variantLength="1" positionVCF="45974685" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>E160fs</ProteinChange>
      <ProteinChange>E217fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45974686dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.45974686dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45509014dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.45509014dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013378.1" sequenceAccession="NG_013378" sequenceVersion="1" change="g.13831dup">
            <Expression>NG_013378.1:g.13831dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013378.2" sequenceAccession="NG_013378" sequenceVersion="2" change="g.13716dup">
            <Expression>NG_013378.2:g.13716dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330540.2" sequenceAccession="NM_001330540" sequenceVersion="2" change="c.477dup">
            <Expression>NM_001330540.2:c.477dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317469.1" sequenceAccession="NP_001317469" sequenceVersion="1" change="p.Glu160fs">
            <Expression>NP_001317469.1:p.Glu160fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015506.3" sequenceAccession="NM_015506" sequenceVersion="3" change="c.648dup" MANESelect="true">
            <Expression>NM_015506.3:c.648dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056321.2" sequenceAccession="NP_056321" sequenceVersion="2" change="p.Glu217fs">
            <Expression>NP_056321.2:p.Glu217fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015506.3(MMACHC):c.648dup (p.Glu217fs) AND Cobalamin C disease" Accession="RCV002811327" Version="2">
        <ClassifiedConditionList TraitSetID="384">
          <ClassifiedCondition DB="MedGen" ID="C1848561">Cobalamin C disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-06-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16311595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19767224</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30157807</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="384" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5516" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cobalamin-C methylmalonic acidemia and homocystinuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic acidemia and homocystinuria cblC type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cobalamin C disease</ElementValue>
                <XRef ID="74653006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">methylmalonic aciduria and homocystinuria type cblC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic aciduria and homocystinuria, Vitamin B12-responsive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vitamin B12 metabolic defect with combined deficiency of methylmalonyl-CoA mutase and homocysteine:methyltetrahydrofolate methyltransferase</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12128" />
                <XRef ID="12128" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="26" DB="Orphanet" />
              <XRef ID="79282" DB="Orphanet" />
              <XRef ID="C1848561" DB="MedGen" />
              <XRef ID="MONDO:0010184" DB="MONDO" />
              <XRef Type="MIM" ID="277400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5892809" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16825458|MedGen:C1848561" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003204102" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16311595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19767224</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30157807</ID>
          </Citation>
          <Comment>This variant is present in population databases (rs773968018, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with MMACHC-related conditions. This variant disrupts a region of the MMACHC protein in which other variant(s) (p.Tyr222*) have been determined to be pathogenic (PMID: 16311595, 19767224, 30157807). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Glu217Argfs*28) in the MMACHC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acid(s) of the MMACHC protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MMACHC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.45974685_45974686insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848561" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5892809" TraitType="Disease" MappingType="XRef" MappingValue="C1848561" MappingRef="MedGen">
        <MedGen CUI="C1848561" Name="Cobalamin C disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

